We are live on
!
Find out more
MA
MYDA Advisors Portfolio holdings
AUM
$672M
1-Year Est. Return
71.14%
This Fund
S&P 500
This Quarter
Est. Return
+31.88%
1 Year Est. Return
+71.14%
3 Year Est. Return
+231.62%
5 Year Est. Return
+315.14%
10 Year Est. Return
–
AUM
$198M
AUM Growth
+$140M
(+241%)
Cap. Flow
+$53.2M
Cap. Flow
% of AUM
26.82%
Top 10 Holdings %
Top 10 Hldgs %
41.19%
Holding
150
New
87
Increased
18
Reduced
6
Closed
37
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
+$11.1M |
| 2 |
Netflix
NFLX
|
+$8.67M |
| 3 |
Amazon
AMZN
|
+$8.32M |
| 4 |
Alerian MLP ETF
AMLP
|
+$5.78M |
| 5 |
Boyd Gaming
BYD
|
+$4.85M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 Value ETF
IWN
|
+$4.3M |
| 2 |
Take-Two Interactive
TTWO
|
+$3.49M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.26M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$2.97M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$2.55M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 52.46% |
| 2 | Consumer Discretionary | 12.41% |
| 3 | Healthcare | 11.38% |
| 4 | Communication Services | 9.73% |
| 5 | Consumer Staples | 3.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Guardant Health
GH
$21.7B
| $920K | 0.46% |
+12,000
| New | +$665K |
|
52
PUT
State Street SPDR S&P Retail ETF
XRT
$285M
| $900K | 0.45% |
+20,000
| New | +$889K |
|
53
Carvana
CVNA
$53.7B
| $871K | 0.44% |
+75,000
| New | +$631K |
|
|
GTT
54
DELISTED
GTT Communications, Inc.
GTT
| $868K | 0.44% |
+25,000
| New | +$734K |
|
|
AVDR
55
DELISTED
Avedro, Inc Common Stock
AVDR
| $859K | 0.43% |
+70,000
| New | +$875K |
|
|
ZEN
56
PUT
DELISTED
ZENDESK INC
ZEN
| $850K | 0.43% |
+10,000
| New | +$734K |
|
57
Innovative Industrial Properties
IIPR
$1.58B
| $817K | 0.41% |
+10,000
| New | +$676K |
|
58
Lyft
LYFT
$6.33B
| $783K | 0.39% |
+10,000
| New | +$783K |
|
59
CALL
Southwest Airlines
LUV
$19.4B
| $727K | 0.37% |
+14,000
| New | +$739K |
|
60
Natera
NTRA
$47.3B
| $722K | 0.36% |
+35,000
| New | +$548K |
|
61
Establishment Labs
ESTA
$2.21B
| $721K | 0.36% |
30,000
-2,000
| -6% | -$53.1K |
|
|
NTRP
62
DELISTED
Neurotrope, Inc. Common
NTRP
| $690K | 0.35% |
+126,685
| New | +$545K |
|
|
I
63
CALL
DELISTED
INTELSAT S. A.
I
| $658K | 0.33% |
42,000
+2,000
| +5% | +$42.4K |
|
|
ZNGA
64
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $640K | 0.32% |
120,000
-105,000
| -47% | -$505K |
|
|
HTT
65
CALL
High Templar Tech Ltd
HTT
$405M
| $638K | 0.32% |
126,000
+74,000
| +142% | +$394K |
|
|
CRON
66
Cronos Group
CRON
$1.2B
| $590K | 0.3% |
+32,000
| New | +$601K |
|
|
HUYA
67
CALL
Huya Inc
HUYA
$484M
| $563K | 0.28% |
+20,000
| New | +$447K |
|
68
Marker Therapeutics
MRKR
$19.7M
| $548K | 0.28% |
+8,297
| New | +$484K |
|
|
TBCH
69
Turtle Beach Corp
TBCH
$224M
| $545K | 0.27% |
48,000
-32,000
| -40% | -$482K |
|
70
PUT
Darling Ingredients
DAR
$10.3B
| $541K | 0.27% |
+25,000
| New | +$528K |
|
71
Noodles & Co
NDLS
$85.4M
| $527K | 0.27% |
9,688
-4,562
| -32% | -$263K |
|
72
Annaly Capital Management
NLY
$17.2B
| $500K | 0.25% |
+12,500
| New | +$510K |
|
73
Viking Therapeutics
VKTX
$4.07B
| $497K | 0.25% |
50,000
+35,000
| +233% | +$293K |
|
|
CLVS
74
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
| $496K | 0.25% |
20,000
-10,000
| -33% | -$251K |
|
|
ATH
75
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
| $490K | 0.25% |
+12,000
| New | +$514K |
|
Similar funds
CFP
MPW
PIWA
AT
ACM
PFG
TC
SWC
MYDA Advisors's Q1 2019 Portfolio in Review
As of Q1 2019, MYDA Advisors held 150 positions worth $198M, up 241% from $58.2M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
MYDA Advisors deployed $53.2M of net new capital in Q1 2019, opening 87 new positions and adding to 18 existing holdings. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 74,500 shares worth $12.6M.
By sector, the portfolio is most concentrated in Miscellaneous at 52% of assets, down from 56% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was ZYNGA INC. CL A COMMON, an estimated $505K trimmed.
- MYDA Advisors's largest Q1 2019 buy was GW Pharmaceuticals Plc American Depositary Shares: 74,500 shares worth $12.6M.
- MYDA Advisors added most to Netflix in Q1 2019, an estimated $8.67M increase.
- MYDA Advisors's biggest Q1 2019 reduction was ZYNGA INC. CL A COMMON, cutting an estimated $505K.
- MYDA Advisors fully exited iShares Russell 2000 Value ETF in Q1 2019, selling an estimated $4.3M.
- MYDA Advisors's ten largest holdings make up 41% of its $198M portfolio in Q1 2019.
- MYDA Advisors opened 87 new positions and closed 37 in Q1 2019.
- MYDA Advisors's portfolio value rose 241% quarter-over-quarter to $198M.
Based on MYDA Advisors's 13F filing for Q1 2019, filed 13 May 2019.